Evidence map›Paper›PMID 39164522›Full record

ArticleOncogene2024

Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells.

Eloïse M Grasset, Atul Deshpande, Jae W Lee, Yeonju Cho, Sarah M Shin, Erin M Coyne, Alexei Hernandez, Xuan Yuan, Zhehao Zhang, Ashley Cimino-Mathews and 2 more

Abstract read
In one paragraph

Article in Oncogene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Eloïse M GrassetUniversité de Nantes, INSERM, CNRS, CRCI2NA, Nantes, France. Eloise.grasset@inserm.fr.ORCID 0000-0001-9857-582X
Atul DeshpandeDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Jae W LeeDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Yeonju ChoDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.ORCID 0009-0003-3983-8337
Sarah M ShinDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Erin M CoyneDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-0393-6600
Alexei HernandezDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Xuan YuanDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Zhehao ZhangDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Ashley Cimino-MathewsDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
Andrew J EwaldDepartment of Cell Biology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1964-0740
Won Jin HoDepartment of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. wjho@jhmi.edu.ORCID 0000-0003-2644-5086

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Tech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Andrew Josef Ewald · 2022 to 2026
$10.2M
Mapping the single cell state basis of metastasis in space and timeU01CA284090 · NCI · JOHNS HOPKINS UNIVERSITY · PI Andrew Josef Ewald · 2023 to 2026
$2.7M
Mass Cytometer CyTOF XT for Single-Cell BiologyS10OD034407 · OD · JOHNS HOPKINS UNIVERSITY · PI HO, WON JIN · 2024 to 2024
$499k
Immunophenotype Integration for Monitoring T Cell Dynamics in Pancreatic CancersR21CA264004 · NCI · JOHNS HOPKINS UNIVERSITY · PI HO, WON JIN · 2021 to 2021
$421k
Breast Cancer Research Foundation (BCRF) 23-048NCI NIH HHS P30 CA006973NCI NIH HHS R21 CA264004NCI NIH HHS U01 CA284090NCI NIH HHS U54 CA268083NIH HHS S10 OD034407U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA006973U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R21CA264004U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U01CA284090U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U54CA268083
6 · The paper itself

Abstract

Metastasis is responsible for the majority of cancer-related fatalities. We previously identified specific cancer cell populations responsible for metastatic events which are cytokeratin-14 (CK14) and E-cadherin positive in luminal tumors, and E-cadherin and vimentin positive in triple-negative tumors. Since cancer cells evolve within a complex ecosystem comprised of immune cells and stromal cells, we sought to decipher the spatial interactions of these aggressive cancer cell populations within the tumor microenvironment (TME). We used imaging mass cytometry to detect 36 proteins in tumor microarrays containing paired primary and metastatic lesions from luminal or triple-negative breast cancers (TNBC), resulting in a dataset of 1,477,337 annotated cells. Focusing on metastasis-initiating cell populations, we observed close proximity to specific fibroblast and macrophage subtypes, a relationship maintained between primary and metastatic tumors. Notably, high CK14 in luminal cancer cells and high vimentin in TNBC cells correlated with close proximity to specific macrophage subtypes (CD163

Indexed as

MacrophagesTriple Negative Breast NeoplasmsTumor MicroenvironmentBreast NeoplasmsCell Line, TumorFemaleHumansNeoplasm MetastasisNeoplastic Stem CellsVimentinVimentin

Identifiers

PMID39164522
PMCPMC12268993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.